Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 6/14/2014
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||J005626 / -||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Chronic fatigue syndrome, Dysphonia, Lethargy, Post viral fatigue syndrome, Oropharyngeal pain
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: No other medications
Current Illness: Immunisation; Food allergy
Diagnostic Lab Data:
CDC 'Split Type': WAES1402GBR009070
Write-up:Information has been received from SPMSD (manufacturer control number E2014-01379) on 18-FEB-2014. This case was received from health authority in a foreign country on 13-FEB-2014. GB-MHRA ADR 22414463. The case is medically confirmed. A 13 year old female patient, with medical history of allergy to nuts, received an injection of GARDASIL, (batch number J005626) 0.5 mL intramuscularly, dose in series and site of administration not reported, on 12-NOV-2013. On 06-DEC-2013, the patient developed sore throat, hoarse voice and lethargy with symptoms worsening, following vaccination. The patient was unable to attend school full time and was experiencing prolonged periods of lethargy. General practitioner has diagnosed chronic fatigue syndrome and myalgic encephalopathy which started on 06-DEC-2013, and referred to paediatricians for further investigation and management. At the time of reporting, the patient has not recovered from all the adverse events. The regulatory authority considered that case serious due to the patient''s disability.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166